Association between serum α-L-fucosidase and non-alcoholic fatty liver disease: Cross-sectional study

Figure 1 Prevalence rates of metabolic syndrome and its five components in patients with different quartile levels of α-L-fucosidase.

Figure 2 Receiver operating characteristic curve of α-L-fucosidase plotted for diagnosis of non-alcoholic fatty liver disease. The area under the curve (diagnostic efficacy index) is 0.606.